Joint fluid testing for periprosthetic joint infection and rheumatoid arthritis

Joint fluid testing for periprosthetic infections and rheumatoid arthritis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400093447

Enrollment

Unknown

Registered

2024-12-05

Start date

2024-12-05

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periprosthetic joint infection

Interventions

group PJI:none

group RA:none

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) The patient's age is between 18-85 years old (including boundary values), except for pregnant women; (2) Patients diagnosed with PJI or RA who require joint puncture; (3) The patient voluntarily participates in the clinical trial and is willing to sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with combined knee joint tumors; (2) Pregnant or lactating women, or patients with fertility plans during clinical studies; (3) Other situations that researchers consider unsuitable for participation in the study;

Design outcomes

Primary

Measure	Time frame
Routine testing of joint fluid;Western Blot;single cell RNA-seq;	—

Countries

China

Contacts

Public ContactRui Li

The Fourth Medical Centre, Chinese PLA General Hospital

zhanghaochong1@163.com+86 158 1001 0301

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026